Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.

This study is enrolling participants by invitation only.
Sponsor:
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00355927
First received: July 23, 2006
Last updated: November 1, 2007
Last verified: August 2006

July 23, 2006
November 1, 2007
September 2006
Not Provided
Changes in the electrical activity of neuron cells of the basal ganglia in the examined patients [ Time Frame: Within 24 hours needed to analyse the data ]
Changes of the electrical activity of single neurons due to propofol sedation.
Complete list of historical versions of study NCT00355927 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.
Changes of the Neuronal Activity in the Subthalamic Nucleus Under Propofol Sedation During Stereotactic Electrode Implantation.

The purpose of this study is to detect possible changes in the electrical activity of the Basal Ganglia related to sedation during deep brain stimulation surgery.

Deep Brain Stimulation is commonly used for the treatment of movement disorders. Electrode positioning is usually performed under local anesthesia in fully awake patients. The procedure is uncomfortable to the patients who have to remain motionless during the whole surgery. Previous reports of electrode positioning under general anesthesia was found to be less accurate. This result was probably due to the effect of the anesthetics on the electrical activity of the Basal Ganglia.

The purpose of this study is to detect possible changes in the electrical activity of the Basal Ganglia related to propofol sedation. Electrical activity of single neurons will be recorded before and after sedation.

Interventional
Not Provided
Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
  • Movement Disorders
  • Parkinson Disease
  • Parkinsonian Disorders
  • Dystonia
  • Tourette Syndrome
Procedure: Sedation with IV propofol
Propofol(50 microgram/kg/min.), I.V. for 5-10 minutes, Until a level of light sedation is achieved
Other Name: DIPROFOL 1%; TAROPharmceutical Indusries Ltd. IL.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Enrolling by invitation
20
July 2008
Not Provided

Inclusion Criteria:

  • Candidate for Deep Brain Stimulation Surgery.
  • Informed concent obtained.

Exclusion Criteria:

  • Suspected difficult intubation (by history or physical examination).
  • Allergy to Propofol, eggs or soy-beans.
  • History of sleep apnea syndrome.
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
Israel
 
NCT00355927
DBSsed1-HMO-CTIL, HTA3769
No
Not Provided
Hadassah Medical Organization
Not Provided
Principal Investigator: Dan Eimerl, MD Hadassah Medical Organization
Principal Investigator: Zvi Israel, MD Hadassah Medical Organization
Hadassah Medical Organization
August 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP